Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

#Rising Cost & #Inflation Leads To 3rd Time Price Rise In #Japan’s McDonald’s Menu Within 10 Months – $MCD $DIA $INVO

By John F. Heerdink, Jr.

Reportedly, the Japanese operator of McDonald’s Corporation (MCD) restaurants announced a price hike for the third time in less than a year marking a compounding inflationary pressure on the nation’s consumers. McDonald’s Holding Company Japan Ltd informed price raise on about 80% of its menu from January 16, due to currency fluctuations as well as surging costs for materials, labor, transportation, and energy.

The hikes follow previous increases in March and September last year, as Japan grapples with inflation and a slide in the yen that has made imported ingredients more expensive. The price for a single cheeseburger will go up to 200 yen ($1.49) this month from 140 yen a year ago. The cost of the signature Big Mac hamburger will go up to 450 yen from 410 yen previously. Japanese consumers will see price increases on more than 4,000 food items from next month.

McDonald’s Corporation (MCD) is the leading global foodservice retailer with nearly 37,000 locations in over 100 countries. The Corporation operates and franchises McDonald’s restaurants in the US and globally, with over 90% of its restaurants owned and operated by local, independent businessmen and women. To learn more about McDonald’s Corporation (MCD) and to track its progress please visit the Vista Partners McDonald’s, Coverage Page


Fertility rates have hit a record low in the United States. The latest US government fertility statistics come from 2019, and they estimate there were 58.2 births year per 1,000 women of childbearing age (defined by the CDC as women between ages 15 and 44).

If you have ever struggled with infertility issues, or know someone who has, you are probably well aware of how demoralizing it can be. Imagine for a moment spending thousands of dollars and months of intensive medical procedure only to end up empty handed, exhausted, sad, and defeated because after all of that time, work, and money, you still don’t have a baby. That’s an incredibly difficult situation, and it’s becoming more common each passing year. Likewise, the need for more effective, less invasive infertility treatment options is increasing with each passing year. This is the sole focus of medtech company INVO Bioscience (NASDAQ: INVO). Learn more by reading the following story that we published recently. 

INVO Bioscience (NASDAQ: $INVO), A Company Seeking To Address A Massively Underserved Fertility Market

Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also provides select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives. 

Stay Informed! Stay Competitive! Please join us at Vista Partners, receive our FREE email updates throughout the week, and view our exclusive content and research.
(Read Original Story: McDonald's Japan hikes prices for 3rd time in 10 months on surging costs in Reuters)


Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Connect with us